The results demonstrated that both glycated casein and casein administration significantly attenuated DSS-induced colitis in mice by alleviating endotoxemia, reducing systematic and colonic inflammation, decreasing neutrophil-derived MPO activity, as well as regulating the TLR4/NF-kB signaling pathway. The gene discussed is TLR4; the disease is serum lipopolysaccharide activity.